CatalystEU/UK

ELI LILLY AND NOVO NORDISK CANT TREAT THIS FORM OF OBESITY . BILLIONAIRE STANLEY DRUCKENMILLER IS BETTING RHYTHM PHARMACEUTICALS CAN

Billionaire Druckenmiller’s bet signals high conviction in Rhythm’s obesity drug amid Eli Lilly and Novo’s coverage gap.

What changed

Why it matters

Billionaire Druckenmiller’s bet signals high conviction in Rhythm’s obesity drug amid Eli Lilly and Novo’s coverage gap.

Sources